We identified O-GlcNAcylation as a critical regulator of MITF activity, driving resistance to CDK4/6 inhibitors in breast cancer.
We developed DARIC (Differential Analysis of Regulated In-Compartments) to systematically identify significant chromosomal compartmentalization changes from Hi-C data.
Using PROTAC technology, we resolved the precise kinetics of hemoglobin switching, revealing that transcription activation precedes chromatin remodeling.
We uncovered a direct competition mechanism between BCL11A and other activators at the gamma-globin promoter, determining the developmental switch.